Informaçao sobre o Autor

Юренева, Светлана Владимировна

Edição Seção Título Arquivo
Nº 3 (2011) Articles OPTIMIZATION OF ANTIRESORPTIVE THERAPY WITH BISPHOSPHONATES
Nº 5 (2012) Articles THE CLINICAL AND PROGNOSTIC VALUE OF HYPOVITAMINOSIS D IN POSTMENOPAUSAL OSTEOPOROSIS
Nº 11 (2013) Articles PATHOGENETIC BASES FOR THE DEVELOPMENT OF AN ACUTE PHASE RESPONSE TO INTRAVENOUS ADMINISTRATION OF NITROGEN-CONTAINING BISPHOSPHONATES
Nº 2 (2014) Articles Vaginal atrophy
Nº 3 (2014) Articles FEMALE REPRODUCTIVE SYSTEM AGING: FROM THEORY TO CLINICAL PRACTICE PART 1. THE ENDOCRINE AND CLINICAL CHARACTERISTICS OF FEMALE REPRODUCTIVE SYSTEM AGING STAGES
Nº 4 (2014) Articles Female reproductive system aging: From theory to clinical practice. Part 2. Role of hormone therapy in solving the problems of transition stage and early postmenopause
Nº 8 (2014) Articles Non-instrumental screening for low bone mineral density in women with secondary amenorrhea
Nº 11 (2014) Articles Prevalence of vulvovaginal atrophy and its impact on quality of life in women. The issues of terminology and the safety of local hormone therapy
Nº 6 (2015) Articles OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: THERAPY WITH TRANSDERMAL ESTROGENS ALONE OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST METABOLIC RISKS AND ARTERIAL THROMBOSIS
Nº 5 (2015) Articles OPTIMIZATION OF MENOPAUSAL HORMONE THERAPY-RELATED RISKS: MONOTHERAPY WITH TRANSDERMAL ESTROGENS OR IN COMBINATION WITH MICRONIZED PROGESTERONE. ADVANTAGES AGAINST VENOUS THROMBOEMBOLISM AND BREAST CANCER
Nº 12 (2015) Articles VULVOVAGINAL ATROPHY: SYMPTOMS, IMPACT ON EMOTIONAL WELL-BEING, QUALITY, AND SEXUAL FUNCTION
Nº 6 (2016) Articles Alternative methods for the treatment of vasomotor symptoms in postmenopausal women
Nº 5 (2016) Articles GENITOURINARY SYNDROME OF MENOPAUSE IN PERI- AND POSTMENOPAUSAL PATIENTS: DIAGNOSIS AND THERAPY (short clinical guidelines)
Nº 9 (2016) Articles VENOUS THROMBOEMBOLISM AND COMBINED ORAL CONTRACEPTION
Nº 3 (2017) Articles Menopausal hormone therapy and risk of coronary heart disease
Nº 8 (2017) Articles Role of hypothalamic (trigger) neuropeptides in the genesis of hot flushes. Prospects for new therapeutic approaches to treating vasomotor menopausal symptoms
Nº 11 (2017) Articles Menopausal hormone therapy and cervical cancer: A current view of the problem
Nº 4 (2018) Articles Characteristics of risk factors for dementia in women: a possible preventive role of menopausal hormone therapy
Nº 6 (2018) Articles Evolution of the goals of menopausal hormone therapy. From treatment for hot flushes to the new horizons of cardiometabolic protection
Nº 1 (2019) Articles Menopausal vasomotor symptoms: social aspects, dynamics, cardiometabolic risks, hormone therapy options
Nº 5 (2019) Articles Menopause, obesity, and comorbidity: possibilities of menopausal hormone therapy
Nº 11 (2019) Articles Relationship between the symptoms of vulvovaginal epithelial atrophy and the vaginal microbiota in postmenopausal women
Nº 11 (2019) Articles The role of neurokinin B in the pathophysiological mechanisms of vasomotor symptoms and sleep disturbances in postmenopausal women
Nº 2 (2020) Articles Weight gain in perimenopausal women: methods for assessing the body composition and maintenance tactics
Nº 2 (2020) Articles Management of menopausal women with a history of endometriosis
Nº 3 (2020) Articles Risk and benefits of menopausal hormonal therapy
Nº 12 (2020) Articles The role of lipids determined by a mass spectrometry method in the development of cardiometabolic diseases in menopausal women
Nº 6 (2021) Articles Surgical menopause as a risk factor for the early development of comorbid conditions in reproductive-aged women
Nº 9 (2021) Articles Menopausal hormone therapy for rheumatic diseases (gout)
Nº 12 (2021) Articles Menopausal hormone therapy for rheumatic diseases: osteoarthritis
Nº 8 (2022) Articles Impact of menopausal hormone therapy on the development and progression of cervical and endometrial cancers
Nº 11 (2021) Articles Evaluation of patients’ satisfaction with Angeliq Micro in real clinical practice after 13 cycles of treatment in Russia
Nº 10 (2022) Articles Analysis of treatment satisfaction in patients with premature ovarian failure
Nº 6 (2022) Articles Changes in serum lipid profile during the menopausal transition
Nº 11 (2022) Articles Contraception in cancer survivors: Breast and gynecological cancers (Part I)
Nº 12 (2022) Articles Contraception in patients with a history of cancer: skin, gastrointestinal, hematological, and endocrine cancers (Part II)
Nº 11 (2022) Articles Pathogenic variants in the BRCA 1 and BRCA2 genes: what is important for a practicing gynecologist to know
Nº 2 (2022) Articles Diagnostic value of anthropometric characteristics of obesity in women during the menopause transition
Nº 10 (2016) Articles POSSIBILITIES OF LOW-DOSE LOCAL ESTRIOL THERAPY IN POSTMENOPAUSAL WOMEN WITH VULVOVAGINAL ATROPHY
Nº 6 (2017) Articles THERAPY FOR VULVOVAGINAL ATROPHY IN POSTMENOPAUSAL WOMEN: CLINICAL AND PATHOGENETIC ASPECTS
Nº 4 (2023) Reviews Impact of hormone therapy on the overall and relapse-free survival of patients receiving treatment for ovarian cancer
Nº 4 (2023) Original Articles Impact of menopausal hormone therapy on immune system parameters
Nº 5 (2023) Original Articles Quality of life in patients with premature ovarian insufficiency treated with hormone replacement therapy
Nº 6 (2023) Reviews Impact of systemic menopausal hormone therapy on symptoms of urinary incontinence in postmenopausal women
Nº 8 (2023) Clinical Notes Resolution of the Council of Experts in obstetrics-gynecology, dermatovenerology, gastroenterology and microbiology "Principles of intimate hygiene in healthy women and in vulvar diseases"
Nº 11 (2023) Clinical Notes Russian eligibility criteria for menopausal hormone therapy in patients with cardiovascular and metabolic diseases

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies